image stringlengths 20 66 | question stringclasses 16
values | answer stringlengths 3 10.7k |
|---|---|---|
PMC9412378_viruses-14-01689-f003_384720.jpg | Describe the main subject of this image. | Immunocytochemistry of anti-IBDV; 5A10 mAb, 2 days pi. (a) In the very virulent virus infected birds, the majority of 5A10 positive cells are located close to the CMEA(s) and they are able to assemble in the periphery of the cortex. Many individual cells are between the CMEA(s) and periphery of the cortex. Follicles ar... |
PMC9412395_vaccines-10-01290-f007_384724.jpg | What can you see in this picture? | (A) Histotopogram of macaque representative lung samples taken on the 6th day after the infection of rhesus macaques with the SARS-CoV-2; (B) IHC-reaction to S-protein (brown reaction product) in representative lung tissues of rhesus macaque (1—control, 2—5 μg dose, 3—20 μg dose); stained with hematoxylin; magnificatio... |
PMC9412395_vaccines-10-01290-f007_384728.jpg | What key item or scene is captured in this photo? | (A) Histotopogram of macaque representative lung samples taken on the 6th day after the infection of rhesus macaques with the SARS-CoV-2; (B) IHC-reaction to S-protein (brown reaction product) in representative lung tissues of rhesus macaque (1—control, 2—5 μg dose, 3—20 μg dose); stained with hematoxylin; magnificatio... |
PMC9412395_vaccines-10-01290-f007_384730.jpg | Can you identify the primary element in this image? | (A) Histotopogram of macaque representative lung samples taken on the 6th day after the infection of rhesus macaques with the SARS-CoV-2; (B) IHC-reaction to S-protein (brown reaction product) in representative lung tissues of rhesus macaque (1—control, 2—5 μg dose, 3—20 μg dose); stained with hematoxylin; magnificatio... |
PMC9412395_vaccines-10-01290-f007_384729.jpg | What's the most prominent thing you notice in this picture? | (A) Histotopogram of macaque representative lung samples taken on the 6th day after the infection of rhesus macaques with the SARS-CoV-2; (B) IHC-reaction to S-protein (brown reaction product) in representative lung tissues of rhesus macaque (1—control, 2—5 μg dose, 3—20 μg dose); stained with hematoxylin; magnificatio... |
PMC9412395_vaccines-10-01290-f007_384726.jpg | Can you identify the primary element in this image? | (A) Histotopogram of macaque representative lung samples taken on the 6th day after the infection of rhesus macaques with the SARS-CoV-2; (B) IHC-reaction to S-protein (brown reaction product) in representative lung tissues of rhesus macaque (1—control, 2—5 μg dose, 3—20 μg dose); stained with hematoxylin; magnificatio... |
PMC9412396_polymers-14-03324-f011_384733.jpg | What is being portrayed in this visual content? | X-ray image of a rat, intravesical implant (2 × 2) mm, Elastollan + barium sulphate + a-C:H/Cu-mulitilayer coating. The selected concentration of 25% barium sulphate in the base material shows sufficient X-ray contrast. X-ray C-arm, Ziehm Vista, Zoom 2, 11 cm, Ziehm Imaging GmbH, Berlin, Germany. |
PMC9412396_polymers-14-03324-f016_384734.jpg | What key item or scene is captured in this photo? | SEM of implants for urinary bladder rat before implantation. (A) group A, Elastollan + barium sulphate. (B) group B, Elastollan + barium sulphate + a-C:H/Cu-mulitilayer coating. FE-SEM Merlin VP compact (Zeiss, Germany), magnification (A): 1.4 × 103, bar 10 µm, (B): 1.12 × 103, bar 10 µm. |
PMC9412396_polymers-14-03324-f016_384735.jpg | What object or scene is depicted here? | SEM of implants for urinary bladder rat before implantation. (A) group A, Elastollan + barium sulphate. (B) group B, Elastollan + barium sulphate + a-C:H/Cu-mulitilayer coating. FE-SEM Merlin VP compact (Zeiss, Germany), magnification (A): 1.4 × 103, bar 10 µm, (B): 1.12 × 103, bar 10 µm. |
PMC9412399_materials-15-05669-f003_384736.jpg | What is the dominant medical problem in this image? | The temporal changes in biodegradation rate of Mg screws interpreted by a decrease in screw diameter. (A–D) X-ray imaging of femoral head in patients implemented with Mg screws at 1 (A), 3 (B), 6 (C), and 12 (D) months postoperatively. (a–d) Magnified surgical regions in (A–D) for measurement of screw diameter at diffe... |
PMC9412399_materials-15-05669-f003_384737.jpg | What is being portrayed in this visual content? | The temporal changes in biodegradation rate of Mg screws interpreted by a decrease in screw diameter. (A–D) X-ray imaging of femoral head in patients implemented with Mg screws at 1 (A), 3 (B), 6 (C), and 12 (D) months postoperatively. (a–d) Magnified surgical regions in (A–D) for measurement of screw diameter at diffe... |
PMC9412399_materials-15-05669-f003_384743.jpg | What stands out most in this visual? | The temporal changes in biodegradation rate of Mg screws interpreted by a decrease in screw diameter. (A–D) X-ray imaging of femoral head in patients implemented with Mg screws at 1 (A), 3 (B), 6 (C), and 12 (D) months postoperatively. (a–d) Magnified surgical regions in (A–D) for measurement of screw diameter at diffe... |
PMC9412399_materials-15-05669-f003_384742.jpg | What is shown in this image? | The temporal changes in biodegradation rate of Mg screws interpreted by a decrease in screw diameter. (A–D) X-ray imaging of femoral head in patients implemented with Mg screws at 1 (A), 3 (B), 6 (C), and 12 (D) months postoperatively. (a–d) Magnified surgical regions in (A–D) for measurement of screw diameter at diffe... |
PMC9412399_materials-15-05669-f003_384741.jpg | What is the central feature of this picture? | The temporal changes in biodegradation rate of Mg screws interpreted by a decrease in screw diameter. (A–D) X-ray imaging of femoral head in patients implemented with Mg screws at 1 (A), 3 (B), 6 (C), and 12 (D) months postoperatively. (a–d) Magnified surgical regions in (A–D) for measurement of screw diameter at diffe... |
PMC9412399_materials-15-05669-f003_384739.jpg | What is the central feature of this picture? | The temporal changes in biodegradation rate of Mg screws interpreted by a decrease in screw diameter. (A–D) X-ray imaging of femoral head in patients implemented with Mg screws at 1 (A), 3 (B), 6 (C), and 12 (D) months postoperatively. (a–d) Magnified surgical regions in (A–D) for measurement of screw diameter at diffe... |
PMC9412399_materials-15-05669-f003_384738.jpg | What is the principal component of this image? | The temporal changes in biodegradation rate of Mg screws interpreted by a decrease in screw diameter. (A–D) X-ray imaging of femoral head in patients implemented with Mg screws at 1 (A), 3 (B), 6 (C), and 12 (D) months postoperatively. (a–d) Magnified surgical regions in (A–D) for measurement of screw diameter at diffe... |
PMC9412403_pharmaceuticals-15-00964-f002_384751.jpg | What is the main focus of this visual representation? | Thin sections of R. rhodochrous IEGM 1362 as viewed with TEM in cultures grown on nutrient agar (a–c) without (control) or (d–f) with (–)-isopulegol (0.025% v/v) and (g,h) in acute tests with the addition of (–)-isopulegol onto agar with already grown culture. Designations: C, capsular layer; CW, cell wall; CW Ls, cell... |
PMC9412403_pharmaceuticals-15-00964-f002_384746.jpg | What is shown in this image? | Thin sections of R. rhodochrous IEGM 1362 as viewed with TEM in cultures grown on nutrient agar (a–c) without (control) or (d–f) with (–)-isopulegol (0.025% v/v) and (g,h) in acute tests with the addition of (–)-isopulegol onto agar with already grown culture. Designations: C, capsular layer; CW, cell wall; CW Ls, cell... |
PMC9412403_pharmaceuticals-15-00964-f002_384747.jpg | What key item or scene is captured in this photo? | Thin sections of R. rhodochrous IEGM 1362 as viewed with TEM in cultures grown on nutrient agar (a–c) without (control) or (d–f) with (–)-isopulegol (0.025% v/v) and (g,h) in acute tests with the addition of (–)-isopulegol onto agar with already grown culture. Designations: C, capsular layer; CW, cell wall; CW Ls, cell... |
PMC9412403_pharmaceuticals-15-00964-f002_384748.jpg | What stands out most in this visual? | Thin sections of R. rhodochrous IEGM 1362 as viewed with TEM in cultures grown on nutrient agar (a–c) without (control) or (d–f) with (–)-isopulegol (0.025% v/v) and (g,h) in acute tests with the addition of (–)-isopulegol onto agar with already grown culture. Designations: C, capsular layer; CW, cell wall; CW Ls, cell... |
PMC9412418_nanomaterials-12-02877-f002_384754.jpg | What is the central feature of this picture? | SEM diagrams of AZ61 powder: (a) original and (b) after grinding of ball milling. SEM images of Ni-coated CNTs with (c) low magnification and (d) high magnification. |
PMC9412418_nanomaterials-12-02877-f002_384753.jpg | What's the most prominent thing you notice in this picture? | SEM diagrams of AZ61 powder: (a) original and (b) after grinding of ball milling. SEM images of Ni-coated CNTs with (c) low magnification and (d) high magnification. |
PMC9412418_nanomaterials-12-02877-f002_384755.jpg | What can you see in this picture? | SEM diagrams of AZ61 powder: (a) original and (b) after grinding of ball milling. SEM images of Ni-coated CNTs with (c) low magnification and (d) high magnification. |
PMC9412418_nanomaterials-12-02877-f002_384752.jpg | What key item or scene is captured in this photo? | SEM diagrams of AZ61 powder: (a) original and (b) after grinding of ball milling. SEM images of Ni-coated CNTs with (c) low magnification and (d) high magnification. |
PMC9412418_nanomaterials-12-02877-f006_384756.jpg | Can you identify the primary element in this image? | SEM images of hierarchical 0.5 vol.% CNTs/AZ61 composites with different magnifications, (a) ×50, (b) ×2000, (c) ×10,000 and (d) ×30,000. |
PMC9412418_nanomaterials-12-02877-f006_384759.jpg | What is the focal point of this photograph? | SEM images of hierarchical 0.5 vol.% CNTs/AZ61 composites with different magnifications, (a) ×50, (b) ×2000, (c) ×10,000 and (d) ×30,000. |
PMC9412418_nanomaterials-12-02877-f006_384758.jpg | What is shown in this image? | SEM images of hierarchical 0.5 vol.% CNTs/AZ61 composites with different magnifications, (a) ×50, (b) ×2000, (c) ×10,000 and (d) ×30,000. |
PMC9412418_nanomaterials-12-02877-f008_384761.jpg | What can you see in this picture? | HRTEM diagrams of hierarchical 1 vol.% CNTs/AZ61 composites (a) hard phase and soft phase, (b) CNT distribution in hard phase, (c,d) CNT interface. |
PMC9412418_nanomaterials-12-02877-f008_384760.jpg | What does this image primarily show? | HRTEM diagrams of hierarchical 1 vol.% CNTs/AZ61 composites (a) hard phase and soft phase, (b) CNT distribution in hard phase, (c,d) CNT interface. |
PMC9412418_nanomaterials-12-02877-f008_384763.jpg | What is being portrayed in this visual content? | HRTEM diagrams of hierarchical 1 vol.% CNTs/AZ61 composites (a) hard phase and soft phase, (b) CNT distribution in hard phase, (c,d) CNT interface. |
PMC9412441_plants-11-02147-f008_384764.jpg | What is the principal component of this image? | V.unguiculata accession k-6: (a)—seed coat structure, light microscopy (1—palisade layer, 2—hypoderma, 3—parenchyma); (b–e) transverse section of the seed, confocal microscopy, (b)—excitation 405 nm with the emission in 400–475 nm (blue), (c)—excitation 488 nm with the emission in 500–545 nm (green), (d)—excitation 488... |
PMC9412441_plants-11-02147-f009_384771.jpg | What is the principal component of this image? | V. unguiculata accession k-1783: (a)—seed coat structure, light microscopy (1—palisade layer, 2—hypoderma, 3—parenchyma); (b–e)—transverse section of the seed, confocal microscopy, (b)—excitation 405 nm with the emission in 400–475 nm (blue), (c)—excitation 488 nm with the emission in 500–545 nm (green), (d)—excitation... |
PMC9412441_plants-11-02147-f009_384774.jpg | What is the focal point of this photograph? | V. unguiculata accession k-1783: (a)—seed coat structure, light microscopy (1—palisade layer, 2—hypoderma, 3—parenchyma); (b–e)—transverse section of the seed, confocal microscopy, (b)—excitation 405 nm with the emission in 400–475 nm (blue), (c)—excitation 488 nm with the emission in 500–545 nm (green), (d)—excitation... |
PMC9412441_plants-11-02147-f010_384766.jpg | What is the core subject represented in this visual? | V.unguiculata accession k-640: (a)—seed coat structure, light microscopy (1—palisade layer, 2—hypoderma, 3—parenchyma); (b–e)—transverse section of the seed, confocal microscopy, (b)—excitation 405 nm with the emission in 400–475 nm (blue), (c)—excitation 488 nm with the emission in 500–545 nm (green), (d)—excitation 4... |
PMC9412441_plants-11-02147-f010_384765.jpg | What stands out most in this visual? | V.unguiculata accession k-640: (a)—seed coat structure, light microscopy (1—palisade layer, 2—hypoderma, 3—parenchyma); (b–e)—transverse section of the seed, confocal microscopy, (b)—excitation 405 nm with the emission in 400–475 nm (blue), (c)—excitation 488 nm with the emission in 500–545 nm (green), (d)—excitation 4... |
PMC9412441_plants-11-02147-f011_384777.jpg | Describe the main subject of this image. | V. unguiculata accession k-642: (a)—seed coat structure, light microscopy (1—palisade layer, 2—hypoderma, 3—parenchyma); (b–e) transverse section of the seed, confocal microscopy, (b)—excitation 405 nm with the emission in 400–475 nm (blue), (c)—excitation 488 nm with the emission in 500–545 nm (green), (d)—excitation ... |
PMC9412441_plants-11-02147-f012_384768.jpg | What object or scene is depicted here? | V.unguiculata accession k-632341: (a)—seed coat structure, light microscopy (1—palisade layer, 2—hypoderma, 3—parenchyma); (b–e)—transverse section of the seed, confocal microscopy, (b)—excitation 405 nm with the emission in 400–475 nm (blue), (c)—excitation 488 nm with the emission in 500–545 nm (green), (d)—excitatio... |
PMC9412441_plants-11-02147-f012_384769.jpg | What is shown in this image? | V.unguiculata accession k-632341: (a)—seed coat structure, light microscopy (1—palisade layer, 2—hypoderma, 3—parenchyma); (b–e)—transverse section of the seed, confocal microscopy, (b)—excitation 405 nm with the emission in 400–475 nm (blue), (c)—excitation 488 nm with the emission in 500–545 nm (green), (d)—excitatio... |
PMC9412453_pathogens-11-00918-f002_384779.jpg | What is shown in this image? | Macroscopic and microscopic findings in the ovary of a southern tamandua with ovarian filariasis. (A) Gross and (B) microscopic features (longitudinal section through the ovary); encircled: sections of filarial nematodes in ovarian tissue. (C) Ovarian tissue with sections of filarial nematodes next to ovarian follicles... |
PMC9412453_pathogens-11-00918-f002_384786.jpg | What is the dominant medical problem in this image? | Macroscopic and microscopic findings in the ovary of a southern tamandua with ovarian filariasis. (A) Gross and (B) microscopic features (longitudinal section through the ovary); encircled: sections of filarial nematodes in ovarian tissue. (C) Ovarian tissue with sections of filarial nematodes next to ovarian follicles... |
PMC9412453_pathogens-11-00918-f002_384781.jpg | Describe the main subject of this image. | Macroscopic and microscopic findings in the ovary of a southern tamandua with ovarian filariasis. (A) Gross and (B) microscopic features (longitudinal section through the ovary); encircled: sections of filarial nematodes in ovarian tissue. (C) Ovarian tissue with sections of filarial nematodes next to ovarian follicles... |
PMC9412453_pathogens-11-00918-f002_384780.jpg | What is shown in this image? | Macroscopic and microscopic findings in the ovary of a southern tamandua with ovarian filariasis. (A) Gross and (B) microscopic features (longitudinal section through the ovary); encircled: sections of filarial nematodes in ovarian tissue. (C) Ovarian tissue with sections of filarial nematodes next to ovarian follicles... |
PMC9412453_pathogens-11-00918-f002_384787.jpg | What is the focal point of this photograph? | Macroscopic and microscopic findings in the ovary of a southern tamandua with ovarian filariasis. (A) Gross and (B) microscopic features (longitudinal section through the ovary); encircled: sections of filarial nematodes in ovarian tissue. (C) Ovarian tissue with sections of filarial nematodes next to ovarian follicles... |
PMC9412453_pathogens-11-00918-f002_384784.jpg | What key item or scene is captured in this photo? | Macroscopic and microscopic findings in the ovary of a southern tamandua with ovarian filariasis. (A) Gross and (B) microscopic features (longitudinal section through the ovary); encircled: sections of filarial nematodes in ovarian tissue. (C) Ovarian tissue with sections of filarial nematodes next to ovarian follicles... |
PMC9412453_pathogens-11-00918-f002_384783.jpg | What is the core subject represented in this visual? | Macroscopic and microscopic findings in the ovary of a southern tamandua with ovarian filariasis. (A) Gross and (B) microscopic features (longitudinal section through the ovary); encircled: sections of filarial nematodes in ovarian tissue. (C) Ovarian tissue with sections of filarial nematodes next to ovarian follicles... |
PMC9412453_pathogens-11-00918-f002_384778.jpg | Can you identify the primary element in this image? | Macroscopic and microscopic findings in the ovary of a southern tamandua with ovarian filariasis. (A) Gross and (B) microscopic features (longitudinal section through the ovary); encircled: sections of filarial nematodes in ovarian tissue. (C) Ovarian tissue with sections of filarial nematodes next to ovarian follicles... |
PMC9412492_tropicalmed-07-00189-f001_384789.jpg | What is shown in this image? | Ultrasonographic neck evaluation of the patient with ulceroglandular tularemia. (A) The hypoechoic area of 5 cm × 1 cm × 2 cm (green lines) corresponds to inflammatory changes in subcutaneous fat involving the platysma muscle (PM) above the sternocleidomastoid muscle (SCM) with abnormal adherent lymph node (LN); (B) Do... |
PMC9412492_tropicalmed-07-00189-f001_384788.jpg | Can you identify the primary element in this image? | Ultrasonographic neck evaluation of the patient with ulceroglandular tularemia. (A) The hypoechoic area of 5 cm × 1 cm × 2 cm (green lines) corresponds to inflammatory changes in subcutaneous fat involving the platysma muscle (PM) above the sternocleidomastoid muscle (SCM) with abnormal adherent lymph node (LN); (B) Do... |
PMC9412492_tropicalmed-07-00189-f001_384790.jpg | Can you identify the primary element in this image? | Ultrasonographic neck evaluation of the patient with ulceroglandular tularemia. (A) The hypoechoic area of 5 cm × 1 cm × 2 cm (green lines) corresponds to inflammatory changes in subcutaneous fat involving the platysma muscle (PM) above the sternocleidomastoid muscle (SCM) with abnormal adherent lymph node (LN); (B) Do... |
PMC9412501_materials-15-05778-f005_384792.jpg | What is shown in this image? | SEM images at different magnifications of (a) PA11/LDH-NO3, (b) PA11/LDH-HALS1, (c) PA11/LDH-HALS2 and (d) PA11/LDH-HALSadded. |
PMC9412501_materials-15-05778-f005_384795.jpg | What key item or scene is captured in this photo? | SEM images at different magnifications of (a) PA11/LDH-NO3, (b) PA11/LDH-HALS1, (c) PA11/LDH-HALS2 and (d) PA11/LDH-HALSadded. |
PMC9412501_materials-15-05778-f005_384794.jpg | What is the central feature of this picture? | SEM images at different magnifications of (a) PA11/LDH-NO3, (b) PA11/LDH-HALS1, (c) PA11/LDH-HALS2 and (d) PA11/LDH-HALSadded. |
PMC9412509_tomography-08-00172-f001_384797.jpg | What's the most prominent thing you notice in this picture? | Representative Cone Beam Computed Tomography imaging showing interaction between biopsy tool (red arrow head, 21-gauge ArcpointTM needle (Medtronic, Plymouth, Minnesota)) placed through extended working channel (yellow arrow head) of electromagnetic navigation system (superDimension version 7.1 (Medtronic, Plymouth, Mi... |
PMC9412509_tomography-08-00172-f001_384798.jpg | Can you identify the primary element in this image? | Representative Cone Beam Computed Tomography imaging showing interaction between biopsy tool (red arrow head, 21-gauge ArcpointTM needle (Medtronic, Plymouth, Minnesota)) placed through extended working channel (yellow arrow head) of electromagnetic navigation system (superDimension version 7.1 (Medtronic, Plymouth, Mi... |
PMC9412509_tomography-08-00172-f001_384796.jpg | What is the central feature of this picture? | Representative Cone Beam Computed Tomography imaging showing interaction between biopsy tool (red arrow head, 21-gauge ArcpointTM needle (Medtronic, Plymouth, Minnesota)) placed through extended working channel (yellow arrow head) of electromagnetic navigation system (superDimension version 7.1 (Medtronic, Plymouth, Mi... |
PMC9412513_medicina-58-01136-f001_384803.jpg | What is the main focus of this visual representation? | Endoscopic view of rectal lesion: (a) white-light endoscopy; (b) narrow-band imaging; (c) magnified version of the image in (b); (d) magnified endoscopic view after crystal violet staining; (e) the ultrasound image; (f) the white-light image of the scar. |
PMC9412513_medicina-58-01136-f001_384802.jpg | What key item or scene is captured in this photo? | Endoscopic view of rectal lesion: (a) white-light endoscopy; (b) narrow-band imaging; (c) magnified version of the image in (b); (d) magnified endoscopic view after crystal violet staining; (e) the ultrasound image; (f) the white-light image of the scar. |
PMC9412513_medicina-58-01136-f001_384804.jpg | What stands out most in this visual? | Endoscopic view of rectal lesion: (a) white-light endoscopy; (b) narrow-band imaging; (c) magnified version of the image in (b); (d) magnified endoscopic view after crystal violet staining; (e) the ultrasound image; (f) the white-light image of the scar. |
PMC9412513_medicina-58-01136-f001_384801.jpg | Can you identify the primary element in this image? | Endoscopic view of rectal lesion: (a) white-light endoscopy; (b) narrow-band imaging; (c) magnified version of the image in (b); (d) magnified endoscopic view after crystal violet staining; (e) the ultrasound image; (f) the white-light image of the scar. |
PMC9412513_medicina-58-01136-f001_384799.jpg | What does this image primarily show? | Endoscopic view of rectal lesion: (a) white-light endoscopy; (b) narrow-band imaging; (c) magnified version of the image in (b); (d) magnified endoscopic view after crystal violet staining; (e) the ultrasound image; (f) the white-light image of the scar. |
PMC9412513_medicina-58-01136-f002_384808.jpg | Describe the main subject of this image. | Histologic examination: (a–c) histologic biopsy in other hospitals: highly distorted and expanded glandular bodies with atypical changes in glandular epithelial cells (magnification: ×100); (d) histologic biopsy in our hospital: microvascular hyperplasia and musculomucosal hyperplasia. |
PMC9412513_medicina-58-01136-f002_384805.jpg | What is the core subject represented in this visual? | Histologic examination: (a–c) histologic biopsy in other hospitals: highly distorted and expanded glandular bodies with atypical changes in glandular epithelial cells (magnification: ×100); (d) histologic biopsy in our hospital: microvascular hyperplasia and musculomucosal hyperplasia. |
PMC9412513_medicina-58-01136-f002_384807.jpg | What is the focal point of this photograph? | Histologic examination: (a–c) histologic biopsy in other hospitals: highly distorted and expanded glandular bodies with atypical changes in glandular epithelial cells (magnification: ×100); (d) histologic biopsy in our hospital: microvascular hyperplasia and musculomucosal hyperplasia. |
PMC9412520_micromachines-13-01250-f016_384809.jpg | What's the most prominent thing you notice in this picture? | High-resolution transmission electron microscopy of surface defects/matrix micro region (a) TEM, (b) HAADF image with electron diffraction pattern of three regions, (c) EDS map, and (d) HRTEM. |
PMC9412520_micromachines-13-01250-f016_384811.jpg | What is the main focus of this visual representation? | High-resolution transmission electron microscopy of surface defects/matrix micro region (a) TEM, (b) HAADF image with electron diffraction pattern of three regions, (c) EDS map, and (d) HRTEM. |
PMC9412527_vetsci-09-00424-f007_384816.jpg | What is the principal component of this image? | Alfa- actin immunodetection in the (a) ascending aorta of a juvenile male Kogia breviceps, (b) thoracic aorta of an adult male Globicephala macrorhynchus, (c) abdominal aorta of an adult female Mesoplodon densirostris. Brown staining indicates the presence of smcs in the aortic wall. |
PMC9412527_vetsci-09-00424-f007_384814.jpg | Can you identify the primary element in this image? | Alfa- actin immunodetection in the (a) ascending aorta of a juvenile male Kogia breviceps, (b) thoracic aorta of an adult male Globicephala macrorhynchus, (c) abdominal aorta of an adult female Mesoplodon densirostris. Brown staining indicates the presence of smcs in the aortic wall. |
PMC9412543_medicina-58-01005-f005_384818.jpg | What is the main focus of this visual representation? | Postoperative axial (a) and coronal (b) computed tomography images show that the Chaput fracture exhibited good reduction, compression, and fixation (arrow). |
PMC9412551_polymers-14-03316-f006_384823.jpg | What is the main focus of this visual representation? | SEM of (a) pristine h-BN Powder; (b–f) Aligned h-BN/PVA composites at different magnifications. |
PMC9412551_polymers-14-03316-f006_384821.jpg | What does this image primarily show? | SEM of (a) pristine h-BN Powder; (b–f) Aligned h-BN/PVA composites at different magnifications. |
PMC9412551_polymers-14-03316-f006_384820.jpg | What stands out most in this visual? | SEM of (a) pristine h-BN Powder; (b–f) Aligned h-BN/PVA composites at different magnifications. |
PMC9412551_polymers-14-03316-f006_384822.jpg | What is the dominant medical problem in this image? | SEM of (a) pristine h-BN Powder; (b–f) Aligned h-BN/PVA composites at different magnifications. |
PMC9412551_polymers-14-03316-f006_384819.jpg | What is the central feature of this picture? | SEM of (a) pristine h-BN Powder; (b–f) Aligned h-BN/PVA composites at different magnifications. |
PMC9412568_sensors-22-06126-f004_384831.jpg | What is the central feature of this picture? | Visual comparison between low-light image enhancement results in the exemplar image. (a) Input (b) HE [33], (c) SSR [18], (d) MSRCR [34], (e) CVC [35], (f) Dong [36], (g) LIME [28], (h) Jiep [37], (i) Kindle [7], (j) ZERO-DCE [38], (k) ZERO-DCE++ [39], (l) ours. |
PMC9412585_polymers-14-03249-f006_384839.jpg | What is the focal point of this photograph? | Fracture surface of a composite with 10 vol.% of fibers (PNT/ENT) arranged: unidirectionally, at 200× magnification (a) and bidirectionally, at 400× magnification (b). |
PMC9412585_polymers-14-03249-f006_384840.jpg | What's the most prominent thing you notice in this picture? | Fracture surface of a composite with 10 vol.% of fibers (PNT/ENT) arranged: unidirectionally, at 200× magnification (a) and bidirectionally, at 400× magnification (b). |
PMC9412585_polymers-14-03249-f007_384838.jpg | What stands out most in this visual? | Fracture surface of a composite with 20 vol.% of fibers (PNT/ENT) arranged: unidirectionally (a) and bidirectionally (b), at 200× magnification. |
PMC9412585_polymers-14-03249-f008_384841.jpg | What is the principal component of this image? | Fracture surface of a composite with 20 vol.% of fibers (PGO/ENT) arranged: unidirectionally (a) and bidirectionally (b), at 200× magnification. |
PMC9412585_polymers-14-03249-f009_384843.jpg | What is the main focus of this visual representation? | Fracture surface of a bidirectional composite with 30 vol.% fibers (PNT/EGO) at 300× magnification. |
PMC9412585_polymers-14-03249-f009_384844.jpg | What stands out most in this visual? | Fracture surface of a bidirectional composite with 30 vol.% fibers (PNT/EGO) at 300× magnification. |
PMC9412585_polymers-14-03249-f010_384845.jpg | What is the focal point of this photograph? | Fracture surface of a composite with 20 vol.% of fibers (PNT/EGO) arranged: unidirectionally (a) and bidirectionally (b), at 200× magnification. |
PMC9412585_polymers-14-03249-f010_384846.jpg | What can you see in this picture? | Fracture surface of a composite with 20 vol.% of fibers (PNT/EGO) arranged: unidirectionally (a) and bidirectionally (b), at 200× magnification. |
PMC9412587_nutrients-14-03304-f001_384849.jpg | What does this image primarily show? | (a) Height (cm) (b) weight (kg) and (c) BMI (kg/m2) measures for DMD population overlaid on CDC growth charts. |
PMC9412594_pharmaceutics-14-01636-f004_384865.jpg | What is the principal component of this image? | (A) Histological micrographs (10× and 40× magnification) of paw tissues of normal, complete Freund’s adjuvant (CFA) control, Celecoxib (CXB), Celebrex®, previously developed solid dispersion (SD6) and optimal CXB micelles (M3) in CFA-induced rats with H&E staining. Reproduced with permission from [81] © 2020 Elsevier. ... |
PMC9412594_pharmaceutics-14-01636-f004_384861.jpg | What's the most prominent thing you notice in this picture? | (A) Histological micrographs (10× and 40× magnification) of paw tissues of normal, complete Freund’s adjuvant (CFA) control, Celecoxib (CXB), Celebrex®, previously developed solid dispersion (SD6) and optimal CXB micelles (M3) in CFA-induced rats with H&E staining. Reproduced with permission from [81] © 2020 Elsevier. ... |
PMC9412594_pharmaceutics-14-01636-f004_384864.jpg | What does this image primarily show? | (A) Histological micrographs (10× and 40× magnification) of paw tissues of normal, complete Freund’s adjuvant (CFA) control, Celecoxib (CXB), Celebrex®, previously developed solid dispersion (SD6) and optimal CXB micelles (M3) in CFA-induced rats with H&E staining. Reproduced with permission from [81] © 2020 Elsevier. ... |
PMC9412594_pharmaceutics-14-01636-f004_384858.jpg | What is being portrayed in this visual content? | (A) Histological micrographs (10× and 40× magnification) of paw tissues of normal, complete Freund’s adjuvant (CFA) control, Celecoxib (CXB), Celebrex®, previously developed solid dispersion (SD6) and optimal CXB micelles (M3) in CFA-induced rats with H&E staining. Reproduced with permission from [81] © 2020 Elsevier. ... |
PMC9412594_pharmaceutics-14-01636-f004_384866.jpg | What's the most prominent thing you notice in this picture? | (A) Histological micrographs (10× and 40× magnification) of paw tissues of normal, complete Freund’s adjuvant (CFA) control, Celecoxib (CXB), Celebrex®, previously developed solid dispersion (SD6) and optimal CXB micelles (M3) in CFA-induced rats with H&E staining. Reproduced with permission from [81] © 2020 Elsevier. ... |
PMC9412594_pharmaceutics-14-01636-f004_384855.jpg | What does this image primarily show? | (A) Histological micrographs (10× and 40× magnification) of paw tissues of normal, complete Freund’s adjuvant (CFA) control, Celecoxib (CXB), Celebrex®, previously developed solid dispersion (SD6) and optimal CXB micelles (M3) in CFA-induced rats with H&E staining. Reproduced with permission from [81] © 2020 Elsevier. ... |
PMC9412594_pharmaceutics-14-01636-f004_384851.jpg | What stands out most in this visual? | (A) Histological micrographs (10× and 40× magnification) of paw tissues of normal, complete Freund’s adjuvant (CFA) control, Celecoxib (CXB), Celebrex®, previously developed solid dispersion (SD6) and optimal CXB micelles (M3) in CFA-induced rats with H&E staining. Reproduced with permission from [81] © 2020 Elsevier. ... |
PMC9412594_pharmaceutics-14-01636-f004_384862.jpg | Describe the main subject of this image. | (A) Histological micrographs (10× and 40× magnification) of paw tissues of normal, complete Freund’s adjuvant (CFA) control, Celecoxib (CXB), Celebrex®, previously developed solid dispersion (SD6) and optimal CXB micelles (M3) in CFA-induced rats with H&E staining. Reproduced with permission from [81] © 2020 Elsevier. ... |
PMC9412594_pharmaceutics-14-01636-f004_384863.jpg | What does this image primarily show? | (A) Histological micrographs (10× and 40× magnification) of paw tissues of normal, complete Freund’s adjuvant (CFA) control, Celecoxib (CXB), Celebrex®, previously developed solid dispersion (SD6) and optimal CXB micelles (M3) in CFA-induced rats with H&E staining. Reproduced with permission from [81] © 2020 Elsevier. ... |
PMC9412594_pharmaceutics-14-01636-f004_384852.jpg | What object or scene is depicted here? | (A) Histological micrographs (10× and 40× magnification) of paw tissues of normal, complete Freund’s adjuvant (CFA) control, Celecoxib (CXB), Celebrex®, previously developed solid dispersion (SD6) and optimal CXB micelles (M3) in CFA-induced rats with H&E staining. Reproduced with permission from [81] © 2020 Elsevier. ... |
PMC9412594_pharmaceutics-14-01636-f004_384867.jpg | What is the main focus of this visual representation? | (A) Histological micrographs (10× and 40× magnification) of paw tissues of normal, complete Freund’s adjuvant (CFA) control, Celecoxib (CXB), Celebrex®, previously developed solid dispersion (SD6) and optimal CXB micelles (M3) in CFA-induced rats with H&E staining. Reproduced with permission from [81] © 2020 Elsevier. ... |
PMC9412594_pharmaceutics-14-01636-f004_384856.jpg | What key item or scene is captured in this photo? | (A) Histological micrographs (10× and 40× magnification) of paw tissues of normal, complete Freund’s adjuvant (CFA) control, Celecoxib (CXB), Celebrex®, previously developed solid dispersion (SD6) and optimal CXB micelles (M3) in CFA-induced rats with H&E staining. Reproduced with permission from [81] © 2020 Elsevier. ... |
PMC9412594_pharmaceutics-14-01636-f004_384859.jpg | Can you identify the primary element in this image? | (A) Histological micrographs (10× and 40× magnification) of paw tissues of normal, complete Freund’s adjuvant (CFA) control, Celecoxib (CXB), Celebrex®, previously developed solid dispersion (SD6) and optimal CXB micelles (M3) in CFA-induced rats with H&E staining. Reproduced with permission from [81] © 2020 Elsevier. ... |
PMC9412594_pharmaceutics-14-01636-f004_384860.jpg | Describe the main subject of this image. | (A) Histological micrographs (10× and 40× magnification) of paw tissues of normal, complete Freund’s adjuvant (CFA) control, Celecoxib (CXB), Celebrex®, previously developed solid dispersion (SD6) and optimal CXB micelles (M3) in CFA-induced rats with H&E staining. Reproduced with permission from [81] © 2020 Elsevier. ... |
PMC9412594_pharmaceutics-14-01636-f004_384850.jpg | What is the focal point of this photograph? | (A) Histological micrographs (10× and 40× magnification) of paw tissues of normal, complete Freund’s adjuvant (CFA) control, Celecoxib (CXB), Celebrex®, previously developed solid dispersion (SD6) and optimal CXB micelles (M3) in CFA-induced rats with H&E staining. Reproduced with permission from [81] © 2020 Elsevier. ... |
PMC9412594_pharmaceutics-14-01636-f004_384854.jpg | What is the focal point of this photograph? | (A) Histological micrographs (10× and 40× magnification) of paw tissues of normal, complete Freund’s adjuvant (CFA) control, Celecoxib (CXB), Celebrex®, previously developed solid dispersion (SD6) and optimal CXB micelles (M3) in CFA-induced rats with H&E staining. Reproduced with permission from [81] © 2020 Elsevier. ... |
PMC9412607_vetsci-09-00444-f002_384868.jpg | What is the dominant medical problem in this image? | Representative photomicrographs for the histopathologic identification of hyphae morphologically consistent with Pythium sp. (arrows). (A). H&E stain; (B). GMS stain; and (C). PAS stain. |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.